Novartis (NVS) reported $11.83 billion in revenue for the quarter ended March 2024, representing a year-over- year decline of 8.7$1.80 for the same period compares to $1.71 a year ago. The reported revenue represents a surprise of +2.85$11.5 billion. With the consensus EPS estimate being $1.73, the EPS surprise was +4.05%. While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street ex ...